Don't disagree that it's large. But I think this is what makes...

Don't disagree that it's large. But I think this is what makes it a good opportunity. IF that parcel goes, how much will it cost to buy the next 3% of issued capital?

I guess if you believe in the future of ADR, it's a bargain. If you wait until news, I'm guessing there's a fair few sets of eyes on the same parcel (maybe it gets pulled who knows). That's the gamble. Go early, one (read: me) might go bust. Wait for news, and you may miss the first 100%+.

For the record, I don't think this is a slam dunk. But I think the probability is in our favour we go on a decent run. Why? The CEO's company (Bioscience) and partner VC firm didn't just stick in the better part of $1.8m for a 3 month joy ride!